World

U.S. imposes sanctions on Iran over missile attack against Israel

Oct 12, 2024

Washington [US], October 12: The United States announced Friday sanctions targeting Iran's energy trade in light of the Oct. 1 ballistic missile attack launched by the country against Israel.
According to a statement issued by the Department of State, the department "is imposing sanctions on six entities engaged in Iranian petroleum trade and identifying six vessels as blocked property."
Meanwhile, the Department of the Treasury "is issuing a determination that will lead to the imposition of sanctions against any person determined to operate in the petroleum or petrochemical sectors of the Iranian economy," the statement said.
"Additionally, Treasury is sanctioning ten entities and identifying 17 vessels as blocked property for their involvement in shipments of Iranian petroleum and petrochemical products in support of U.S.-designated entities National Iranian Oil Company or Triliance Petrochemical Co. Limited," the statement added.
U.S. National Security Advisor Jake Sullivan said in a statement that the above measures "will help further deny Iran financial resources used to support its missile programs and provide support for terrorist groups that threaten the United States, its allies, and partners."
Source: Xinhua

More news

Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month

Mumbai (Maharashtra) [India], November 22: Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. In India, it continues to be a leading cause of cancer-related mortality. However, advancements in early detection and new treatment options, particularly genetic profiling, are improving survival rates. These innovations are part of precision oncology, a rapidly growing field that customizes treatments based on a patient's unique genetic makeup, enabling personalized care.

Nov 22, 2024